Dr. Lal PathLabs made a fabulous debut and snapped the session at Rs 824.15, a premium of 49.85% or higher by 274.15 points as against its issue price of Rs 550, on BSE.
The shares of the company debuted at Rs 717.00 and touched a high and low of Rs 842.40 and 715.50 respectively. A total of 49,69,000 shares were traded on the counter.
The issue price of Dr. Lal PathLabs was fixed at Rs 550 per share i.e. at the higher end of the price band of Rs 540-550 apiece. The offering was subscribed 33.41 times.
The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer for Sale of up to 11,600,000 Equity Shares.
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 6838.85 |
Max Healthcare Inst | 1082.45 |
Narayana Hrudayalay | 1271.05 |
Aster DM Healthcare | 490.75 |
Global Health | 1028.60 |
View more.. |